ArticleNature communications2023

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation.

Carlos K H Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.